The role of the radiation therapy breast boost in the 2020s
Given that most local relapses of breast cancer occur proximal to the original location of the primary, the delivery of additional radiation dose to breast tissue that contained the original primary cancer (known as a “boost”) has been a standard of care for some decades. In the context of falling r...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-06-01
|
| Series: | Breast |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977623004265 |
| _version_ | 1797804696717492224 |
|---|---|
| author | M. Dzhugashvili L. Veldeman A.M. Kirby |
| author_facet | M. Dzhugashvili L. Veldeman A.M. Kirby |
| author_sort | M. Dzhugashvili |
| collection | DOAJ |
| description | Given that most local relapses of breast cancer occur proximal to the original location of the primary, the delivery of additional radiation dose to breast tissue that contained the original primary cancer (known as a “boost”) has been a standard of care for some decades. In the context of falling relapse rates, however, it is an appropriate time to re-evaluate the role of the boost. This article reviews the evolution of the radiotherapy boost in breast cancer, discussing who to boost and how to boost in the 2020s, and arguing that, in both cases, less is more. |
| first_indexed | 2024-03-13T05:41:05Z |
| format | Article |
| id | doaj.art-d25e75a09e704596944e96d4643ccdca |
| institution | Directory Open Access Journal |
| issn | 1532-3080 |
| language | English |
| last_indexed | 2024-03-13T05:41:05Z |
| publishDate | 2023-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Breast |
| spelling | doaj.art-d25e75a09e704596944e96d4643ccdca2023-06-14T04:32:40ZengElsevierBreast1532-30802023-06-0169299305The role of the radiation therapy breast boost in the 2020sM. Dzhugashvili0L. Veldeman1A.M. Kirby2Genesiscare, SpainGhent University/Ghent University Hospital, Ghent, BelgiumRoyal Marsden Hospital NHS Foundation Trust & Institute of Cancer Research, UK; Corresponding author.Given that most local relapses of breast cancer occur proximal to the original location of the primary, the delivery of additional radiation dose to breast tissue that contained the original primary cancer (known as a “boost”) has been a standard of care for some decades. In the context of falling relapse rates, however, it is an appropriate time to re-evaluate the role of the boost. This article reviews the evolution of the radiotherapy boost in breast cancer, discussing who to boost and how to boost in the 2020s, and arguing that, in both cases, less is more.http://www.sciencedirect.com/science/article/pii/S0960977623004265Breast boost radiotherapy |
| spellingShingle | M. Dzhugashvili L. Veldeman A.M. Kirby The role of the radiation therapy breast boost in the 2020s Breast Breast boost radiotherapy |
| title | The role of the radiation therapy breast boost in the 2020s |
| title_full | The role of the radiation therapy breast boost in the 2020s |
| title_fullStr | The role of the radiation therapy breast boost in the 2020s |
| title_full_unstemmed | The role of the radiation therapy breast boost in the 2020s |
| title_short | The role of the radiation therapy breast boost in the 2020s |
| title_sort | role of the radiation therapy breast boost in the 2020s |
| topic | Breast boost radiotherapy |
| url | http://www.sciencedirect.com/science/article/pii/S0960977623004265 |
| work_keys_str_mv | AT mdzhugashvili theroleoftheradiationtherapybreastboostinthe2020s AT lveldeman theroleoftheradiationtherapybreastboostinthe2020s AT amkirby theroleoftheradiationtherapybreastboostinthe2020s AT mdzhugashvili roleoftheradiationtherapybreastboostinthe2020s AT lveldeman roleoftheradiationtherapybreastboostinthe2020s AT amkirby roleoftheradiationtherapybreastboostinthe2020s |